New diabetes clinical trial: Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005)

Published on: 2026-10-09T04:00:00Z
Conditions: Diabetic Macular Edema (DME)
Interventions: Biological: 4D-150 IVT (3x10^10 vg); Biological: EYELEA ® (aflibercept) Injection 2 mg (0.05mL)
Sponsors: 4D Molecular Therapeutics
Recruiting
https://ift.tt/NLbpDde